Compound 1965
Identifiers
- Canonical SMILES:
COCC(=O)N1CCC(CC1)C(=O)N(C)Cc1cc(Cl)cc(c1O)-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1
- IUPAC name:
N-[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl]-1-(2-methoxyacetyl)-N-methylpiperidine-4-carboxamide
- InChi:
InChI=1S/C30H27Cl2F3N4O5/c1-38(29(43)16-5-7-39(8-6-16)26(40)15-44-2)14-17-9-19(31)11-22(27(17)41)25-12-20(23(13-36)28(42)37-25)21-10-18(30(33,34)35)3-4-24(21)32/h3-4,9-12,16,41H,5-8,14-15H2,1-2H3,(H,37,42)
- InChiKey:
XXQDQNLYFCJEPH-UHFFFAOYSA-N
External links
![]() 44431596 |
![]() CHEMBL234330 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Survivin dimer | 7.19 | cancer | Stabilization |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 650.13 g/mol | |||
HBA | 9 | |||
HBD | 2 | |||
HBA + HBD | 11 | |||
AlogP | 3.13 | |||
TPSA | 120.17 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1016/j.bmcl.2007.03.042 | 25a | BIRC5 O15392 |
|
Biochemical assay | Fluorescence Polarization | pKd (dissociation constant, -log10) | 7.19 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5507 | 6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE | DB08705 | |
0.4455 | 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE | DB07025 | |
0.4409 | Losmapimod | DB12270 | |
0.4403 | Tazemetostat | DB12887 | |
0.4340 | N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE | DB08031 | |
0.4328 | CPI-1205 | DB14581 | |
0.4279 | 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE | DB07075 | |
0.4247 | JPC-3210 | DB15609 | |
0.4245 | Garenoxacin | DB06160 | |
0.4201 | Talnetant | DB06429 | |
0.4189 | Topotecan | DB01030 | |
0.4181 | 9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE | DB07006 | |
0.4144 | Pipendoxifene | DB05414 | |
0.4130 | Proglumetacin | DB13527 | |
0.4116 | Batefenterol | DB12526 |